1. Home
  2. BBIO vs TTC Comparison

BBIO vs TTC Comparison

Compare BBIO & TTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BBIO
  • TTC
  • Stock Information
  • Founded
  • BBIO 2015
  • TTC 1914
  • Country
  • BBIO United States
  • TTC United States
  • Employees
  • BBIO N/A
  • TTC N/A
  • Industry
  • BBIO Biotechnology: Pharmaceutical Preparations
  • TTC Tools/Hardware
  • Sector
  • BBIO Health Care
  • TTC Consumer Discretionary
  • Exchange
  • BBIO Nasdaq
  • TTC Nasdaq
  • Market Cap
  • BBIO 8.8B
  • TTC 7.7B
  • IPO Year
  • BBIO 2019
  • TTC N/A
  • Fundamental
  • Price
  • BBIO $49.08
  • TTC $79.13
  • Analyst Decision
  • BBIO Strong Buy
  • TTC Hold
  • Analyst Count
  • BBIO 16
  • TTC 4
  • Target Price
  • BBIO $61.69
  • TTC $82.00
  • AVG Volume (30 Days)
  • BBIO 2.9M
  • TTC 677.4K
  • Earning Date
  • BBIO 08-05-2025
  • TTC 09-04-2025
  • Dividend Yield
  • BBIO N/A
  • TTC 2.00%
  • EPS Growth
  • BBIO N/A
  • TTC 54.24
  • EPS
  • BBIO N/A
  • TTC 3.89
  • Revenue
  • BBIO $235,812,000.00
  • TTC $4,545,800,000.00
  • Revenue This Year
  • BBIO $106.33
  • TTC N/A
  • Revenue Next Year
  • BBIO $54.30
  • TTC $3.15
  • P/E Ratio
  • BBIO N/A
  • TTC $20.33
  • Revenue Growth
  • BBIO 7.62
  • TTC 2.94
  • 52 Week Low
  • BBIO $21.72
  • TTC $62.34
  • 52 Week High
  • BBIO $51.86
  • TTC $93.00
  • Technical
  • Relative Strength Index (RSI)
  • BBIO 55.76
  • TTC 63.68
  • Support Level
  • BBIO $48.03
  • TTC $75.19
  • Resistance Level
  • BBIO $51.86
  • TTC $78.55
  • Average True Range (ATR)
  • BBIO 1.95
  • TTC 1.73
  • MACD
  • BBIO -0.08
  • TTC 0.24
  • Stochastic Oscillator
  • BBIO 71.55
  • TTC 96.19

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

About TTC Toro Company (The)

The Toro Co manufactures turf maintenance and landscaping equipment. The company produces reel and rotary riding products, trim cutting and walking mowers, greens rollers, turf sprayer equipment, underground irrigation systems, heavy-duty walk-behind mowers, and sprinkler systems used for professional turf and landscape maintenance and construction. Its products are marketed through a network of distributors and dealers to predominantly professional users maintaining turfs and sports fields such as golf courses. Its operating segments are Professional which generates a substantial part of its revenue, and Residential segment. The company also produces snow plowers and ice management products. Its key revenue generating market is the United States.

Share on Social Networks: